Thank you for attending CEU Miami, we are excited that you and your colleagues decided to join us for this comprehensive clinical endocrine program.

CEU 2019 (21.50 points) is certified for both AMA PRA Category 1 Credit(s)™ and ABIM MOC points.

Provide your feedback and claim your CME/MOC credit here

For access to all of the meeting materials please use the mobile app. You can get the app on Google Play or download it in the Apple App Store. Please note, you must log in to the app using your account information (email and password) to view the presentation slides.

If you have any questions or concerns, please contact us at:

CEU Session Recordings Now Available

As a reminder, your registration includes access to CEU 2019 Session Recordings, which are now accessible on your computer, tablet, or on the go with downloadable MP3.

These recordings will allow you to revisit the world-class education you received onsite, and you can earn an additional 28.25 AMA PRA Category 1 Credits™. Access these sessions by logging in with your account information (email and password).

CEU 2019 Supporters

The Endocrine Society would like to thank the following for their support:

  • Corcept Therapeutics
  • Exelixis
  • Lilly USA
  • Merck & Co.
  • Strongbridge Biopharma
  • Xeris Pharmaceuticals

CEU 2019 Miami Exhibitors

AbbVie (Table 20)—AbbVie is a global, research-based biopharmaceutical company which combines the focus of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader.

Aegerion Pharmaceuticals (Table 16)—Aegerion Pharmaceuticals is a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases.

Amneal Pharmaceuticals (Table 17)—Unithroid (Levothyroxine Sodium Tablets USP) indicated in pediatric and adult patients as a replacement therapy in primary, secondary, and tertiary congenital or acquired hypothyroidism.

AstraZeneca (Table 22)—We push the boundaries of science to deliver life-changing medicines.

Companion Medical (Table 14)—Companion Medical is a leader in advanced technology to improve diabetes care. InPen is the first and only FDA-cleared smart pen for insulin delivery.

Corcept Therapeutics (Table 13)— Corcept is a pharmaceutical company engaged in the discovery, and development of drugs that treat metabolic and oncologic disorders by modulating the effects of cortisol.

Crinetics Pharmaceuticals (Table 19)—Crinetics is a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.

Erlanger Health System (Table 15)—Erlanger Health System is a multi-hospital system with seven hospitals based in Chattanooga, TN and is the tristate regions only Level I Trauma Center.

Horizon Therapeutics (Table 6)—Horizon is focused on researching, developing and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases.

Horizon Therapeutics - Medical Affairs (Table 8)—Horizon is focused on researching, developing and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases.

HRA Pharma Rare Diseases (Table 1)—HRA Pharma Rare Diseases is “Devoted to the Rare,” marketing approved products used to diagnose and treat rare endocrine diseases.

Mannkind (Table 7)—Afrezza is an inhaled, ultra-rapid mealtime insulin approved to treat adult patients with Type 1 and Type 2 Diabetes.

Novo Nordisk (Table 4 & 5)—Novo Nordisk, a global health care company, is committed to discovering and developing innovative medicines to help people living with diabetes lead longer, healthier lives.

Pfizer Inc. (Table 3)—At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives.

ProAssurance (Table 10)—ProAssurance professional liability insurance defends healthcare providers facing malpractice claims and provides fair treatment for our insureds. ProAssurance Group is A.M. Best A+ (Superior).

Progenics Pharmaceuticals (Table 18)—Progenics Pharmaceuticals, Inc. is an oncology company focused on the development and commercialization of innovative targeted medicines and other technologies to target and treat cancer.

Salix (Table 25)—For almost 30 years, Salix Pharmaceuticals has been committed to the prevention and treatment of gastrointestinal diseases.

Senseonics (Table 2)—The only CGM system with on-body vibe alerts and lasts up to 90 days. Currently $33 per month for commercially insured patients meeting CGM criteria.

Sonic Healthcare USA (Table 2)—Sonic Healthcare USA is a laboratory services provider that emphasizes medical leadership and community based testing services to provide outstanding service to doctors and patients.

Strongbridge for Novo Nordisk (Table 9)—Macrelin is the first FDA approved, oral stimulation test for AGHD.

Veracyte (Table 21)—The Afirma Genomic Sequencing Classifier and Xpression Atlas provide physicians with a comprehensive solution for a complex landscape in thyroid cancer diagnosis and individualization of care.

VeroScience (Table 23)—CYCLOSET is an FDA-approved sympatholytic insulin sensitizer proven to be cardiovascular safe. CYCLOSET morning administration reduces postprandial hyperglycemia throughout the day without raising plasma insulin.

Wolters Kluwer (Tables 11 & 12) )—Wolters Kluwer Health is a leading global provider of information and point of care solutions for the healthcare industry.

Cancellation Policy

Cancellations must be received in writing by August 5, 2019. No refunds will be issued after that date.
All cancellations are subject to a $75 processing charge.